Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Free Cash Flow (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Free Cash Flow for 6 consecutive years, with $49.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 28.23% year-over-year to $49.7 million, compared with a TTM value of $51.9 million through Dec 2025, up 40.66%, and an annual FY2025 reading of $51.9 million, up 40.66% over the prior year.
  • Free Cash Flow was $49.7 million for Q4 2025 at Viemed Healthcare, up from -$8.9 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $49.7 million in Q4 2025 and bottomed at -$10.5 million in Q3 2024.
  • Average Free Cash Flow over 5 years is $9.2 million, with a median of $6.4 million recorded in 2022.
  • The sharpest move saw Free Cash Flow surged 704.87% in 2021, then crashed 242.08% in 2022.
  • Year by year, Free Cash Flow stood at $8.7 million in 2021, then decreased by 11.22% to $7.7 million in 2022, then skyrocketed by 72.71% to $13.3 million in 2023, then skyrocketed by 191.99% to $38.8 million in 2024, then increased by 28.23% to $49.7 million in 2025.
  • Business Quant data shows Free Cash Flow for VMD at $49.7 million in Q4 2025, -$8.9 million in Q3 2025, and $11.9 million in Q2 2025.